BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 21493587)

  • 1. Relaxin enhances the collagenolytic activity and in vitro invasiveness by upregulating matrix metalloproteinases in human thyroid carcinoma cells.
    Bialek J; Kunanuvat U; Hombach-Klonisch S; Spens A; Stetefeld J; Sunley K; Lippert D; Wilkins JA; Hoang-Vu C; Klonisch T
    Mol Cancer Res; 2011 Jun; 9(6):673-87. PubMed ID: 21493587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxin enhances the oncogenic potential of human thyroid carcinoma cells.
    Hombach-Klonisch S; Bialek J; Trojanowicz B; Weber E; Holzhausen HJ; Silvertown JD; Summerlee AJ; Dralle H; Hoang-Vu C; Klonisch T
    Am J Pathol; 2006 Aug; 169(2):617-32. PubMed ID: 16877360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-WASP coordinates the delivery and F-actin-mediated capture of MT1-MMP at invasive pseudopods.
    Yu X; Zech T; McDonald L; Gonzalez EG; Li A; Macpherson I; Schwarz JP; Spence H; Futó K; Timpson P; Nixon C; Ma Y; Anton IM; Visegrády B; Insall RH; Oien K; Blyth K; Norman JC; Machesky LM
    J Cell Biol; 2012 Oct; 199(3):527-44. PubMed ID: 23091069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxin-2 is a novel biomarker for differentiated thyroid carcinoma in humans.
    Kotwal A; Simpson R; Whiteman N; Swanson B; Yuil-Valdes A; Fitch M; Nguyen J; Elhag S; Shats O; Goldner W; Bennett R
    Biochem Pharmacol; 2024 May; 225():116323. PubMed ID: 38815632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common SNP risk variant MT1-MMP causative for Dupuytren's disease has a specific defect in collagenolytic activity.
    Itoh Y; Ng M; Wiberg A; Inoue K; Hirata N; Paiva KBS; Ito N; Dzobo K; Sato N; Gifford V; Fujita Y; Inada M; Furniss D
    Matrix Biol; 2021 Mar; 97():20-39. PubMed ID: 33592276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of MT1-MMP Activity in Cancer Cells.
    Itoh Y
    Methods Mol Biol; 2024; 2747():151-166. PubMed ID: 38038939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPOCK2 Affects the Biological Behavior of Endometrial Cancer Cells by Regulation of MT1-MMP and MMP2.
    Ren F; Wang D; Wang Y; Chen P; Guo C
    Reprod Sci; 2019 Mar; ():1933719119834341. PubMed ID: 30832559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase collagenolysis in health and disease.
    Amar S; Smith L; Fields GB
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1940-1951. PubMed ID: 28456643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Quantification of Human Relaxin Proteins by Immunoaffinity-Mass Spectrometry.
    Rais Y; Drabovich AP
    J Proteome Res; 2024 Jun; 23(6):2013-2027. PubMed ID: 38739617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Video-rate bioluminescence imaging of matrix metalloproteinase-2 secreted from a migrating cell.
    Suzuki T; Kondo C; Kanamori T; Inouye S
    PLoS One; 2011; 6(9):e25243. PubMed ID: 21969874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific expression and blood kinetics for relaxin 2, lipocalin 2, and tissue factor pathway inhibitor 2 at the canine placenta and pregnant bloods.
    Yustinasari LR; Kuratomi M; Kagawa S; Gondo A; Aramaki N; Imai H; Kusakabe KT
    J Vet Med Sci; 2024 Jan; 86(1):77-86. PubMed ID: 38057091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diverse influences of relaxin-like peptide family on tumor progression: Potential opportunities and emerging challenges.
    Jung J; Han H
    Heliyon; 2024 Jan; 10(2):e24463. PubMed ID: 38298643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and Prognostic Value of m6A RNA Methylation-Related Genes in Thyroid Cancer.
    Han H; Fu X; Zhang Y; Luo D; Zhang X; Wu X
    Iran J Public Health; 2023 Sep; 52(9):1902-1916. PubMed ID: 38033847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dual and multifaceted role of relaxin-2 in cancer.
    Kwantwi LB
    Clin Transl Oncol; 2023 Oct; 25(10):2763-2771. PubMed ID: 36947362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicular Thyroid Adenoma and Follicular Thyroid Carcinoma-A Common or Distinct Background? Loss of Heterozygosity in Comprehensive Microarray Study.
    Borowczyk M; Dobosz P; Szczepanek-Parulska E; Budny B; Dębicki S; Filipowicz D; Wrotkowska E; Oszywa M; Verburg FA; Janicka-Jedyńska M; Ziemnicka K; Ruchała M
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Landscape Analysis of Matrix Metalloproteinases Unveils Key Prognostic Markers for Patients With Breast Cancer.
    Cheng T; Chen P; Chen J; Deng Y; Huang C
    Front Genet; 2021; 12():809600. PubMed ID: 35069702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Expression of the Androgen Receptor, Splice Variants and Relaxin 2 in Renal Cancer.
    Bialek J; Piwonka M; Kawan F; Fornara P; Theil G
    Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel CTRP8-RXFP1-JAK3-STAT3 axis promotes Cdc42-dependent actin remodeling for enhanced filopodia formation and motility in human glioblastoma cells.
    Glogowska A; Thanasupawat T; Beiko J; Pitz M; Hombach-Klonisch S; Klonisch T
    Mol Oncol; 2022 Jan; 16(2):368-387. PubMed ID: 33960104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNRC6C Functions as a Tumor Suppressor and Is Frequently Downregulated in Papillary Thyroid Cancer.
    Cai Z; Zhai T; Muhanhali D; Ling Y
    Int J Endocrinol; 2021; 2021():6686998. PubMed ID: 33564303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF
    Hernandez BY; Rahman M; Loo LWM; Chan OTM; Horio D; Morita S; Bryant-Greenwood G
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):183-194. PubMed ID: 32995956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.